Mark E Delaney, SVP & Chief Commercial Officer at Quest Diagnostics, sold DGX on Jul 28, 2026
Data as of Oct 16
▼ SELL$376K1,600 shares at $235.18Mark E Delaney SVP & Chief Commercial OfficerDGX Quest Diagnostics Inc
- Traded
- Jul 28, 2026
- Disclosed
- Jul 29, 2026
- Filed
- 1 day after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
DGX since disclosure
−0.1%
after the sale
Similar stocks (XLV) since disclosure
+6.3%
XLV — its sector index fund
Change in closing price from Jul 29, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.